A positive CD4+ T-cell response was noted in 41% and 50% of CVID patients at week 6 and 16, respectively, while the combined CD4+/CD8+ assay showed a negative trend over time with 50% and 41% positive at week 6 and 16, respectively.
← all excerpts
Cellular immunity in COVID-19 and other infections in Common variable immunodeficiency.
1
—
—